Evaluation of Biomarkers in Myoma Patients: A Prospective Study Investigating the Role of LDH, CA 125, and IGF-1 after Uterus-Preserving Surgical Therapy.

Jacob, Michaela; Richter, Rolf; Sehouli, Jalid; David, Matthias

Jacob, Michaela; Richter, Rolf; Sehouli, Jalid; David, Matthias.

Afiliação

Jacob M; Department of Gynecology with Center for Oncological Surgery, Campus Virchow Charité University Hospital Berlin, Berlin, Germany.
Richter R; Department of Gynecology with Center for Oncological Surgery, Campus Virchow Charité University Hospital Berlin, Berlin, Germany.
Sehouli J; Department of Gynecology with Center for Oncological Surgery, Campus Virchow Charité University Hospital Berlin, Berlin, Germany.
David M; Department of Gynecology with Center for Oncological Surgery, Campus Virchow Charité University Hospital Berlin, Berlin, Germany, matthias.david@charite.de.

Gynecol Obstet Invest ; 86(1-2): 100-107, 2021.

Article em En | MEDLINE | ID: mdl-33582665

Assuntos

Biomarcadores/sangue; Antígeno Ca-125/sangue; Fator de Crescimento Insulin-Like I/análise; L-Lactato Desidrogenase/sangue; Leiomioma/cirurgia; Neoplasias Uterinas/cirurgia; Abdome/patologia; Adolescente; Adulto; Feminino; Humanos; Leiomioma/sangue; Pessoa de Meia-Idade; Recidiva Local de Neoplasia/sangue; Período Pós-Operatório; Estudos Prospectivos; Ultrassonografia; Neoplasias Uterinas/sangue; Vagina/patologia; Adulto Jovem

Palavras-chave

Biomarker; Insulin-like growth factor 1; Lactate dehydrogenase; Myomas; Uterine fibroids

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Uterinas / Fator de Crescimento Insulin-Like I / Biomarcadores / Antígeno Ca-125 / L-Lactato Desidrogenase / Leiomioma Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google